About Dr. Adil Moulanchikkal

A Clinical Approach Built from Observing What Doesn't Work

Many patients reach EPOH after years of trying everything conventional medicine offers for HS. Dr. Adil Moulanchikkal's approach was not arrived at from theory — it was built from the consistent observation that treating lesions without correcting the internal environment produces a predictable result: recurrence.

BAMS

Bachelor of Ayurvedic Medicine & Surgery

HS

Primary Clinical Focus: Hidradenitis Suppurativa

EPOH

Founder — Evolution of Elite Ayurveda

300

HS Cases in Remission with the EPOH Protocol

Dr. Adil Moulanchikkal

BAMS · Ayurvedic Physician · EPOH

Clinical Background

Why HS Became the Clinical Focus

Hidradenitis Suppurativa is, in many ways, the condition that exposes the limits of symptom-focused medicine most clearly. Patients arrive with years — sometimes decades — of antibiotic courses, repeated surgical procedures, and biologic suppression behind them. Their condition has not resolved; in most cases, it has deepened.

What the clinical pattern consistently showed was that the skin was not the origin of the problem. Gut dysfunction, hormonal imbalance, metabolic dysregulation, and immune overactivation were present in nearly every patient — and they were not being addressed. Managing the lesion without correcting these internal drivers was producing a predictable outcome: the condition returned.

The EPOH HS Protocol™ emerged from this observation — a structured, phase-based approach that addresses HS as a systemic condition, not a dermatological one. Not a theory. A clinical response to a repeating pattern.

A Pattern Seen Across Cases

1

Patients with significant disease duration — often 5, 10, or 15 years — who have tried multiple treatment cycles without sustained resolution

2

Identifiable gut dysfunction — often worsened by repeated antibiotic courses — present in the majority of complex cases

3

Hormonal patterns — particularly androgen dominance and insulin resistance — contributing to flare frequency in women

4

Internal correction — gut restoration, hormonal rebalancing, inflammatory load reduction — producing sustained improvement where surface treatment had not

"Many patients come to us after trying multiple treatments without long-term relief. What they typically have not received is a treatment aimed at the internal environment driving the skin's behaviour."

— Dr. Adil Moulanchikkal, BAMS

Clinical Philosophy

Four Principles That Govern Every Treatment Decision

These are not values statements — they are the practical principles that shape how every patient case is assessed and every treatment plan is constructed at EPOH.

The EPOH approach is rooted in Ayurvedic medicine — not as an alternative to understanding HS, but as the most complete framework for explaining why it occurs, why it recurs, and what internal sequence resolves it.

Dr. Adil Moulanchikkal, BAMS · Founder, EPOH

Principle 01

The Skin Is Not the Origin

HS lesions are a surface expression of internal dysfunction. Treating the skin is not wrong — but treating only the skin misses where the disease actually lives. Every treatment decision begins with the internal environment: gut function, hormonal state, immune signalling, metabolic health. The skin is addressed within that context, not independently of it.

Principle 02

Recurrence Is a Clinical Signal, Not an Inevitability

When HS recurs — after antibiotics, after surgery, after suppression — most patients are told this is simply the nature of the condition. The EPOH position is different: recurrence indicates that the underlying driver has not been corrected. It is not a passive observation; it is a clinical question. What is sustaining this? What has not been addressed?

Principle 03

Personalisation Is Not Optional

Two patients with Stage II HS may have entirely different driver profiles — one primarily gut-driven, one primarily hormonal, one primarily metabolic. Applying the same formulation to both patients is not clinical practice; it is a protocol. EPOH does not use protocols in that sense. Every treatment plan is constructed from the patient's specific pattern, not from a category.

Principle 04

Honesty About Limits Is Part of Clinical Integrity

Not every patient will achieve full remission. Advanced fibrotic cases, irreversible organ involvement, and complete pancreatic failure create biological limits where correction is not possible. Saying so clearly — rather than offering false hope — is a clinical obligation. The evaluation process at EPOH exists partly to make this determination before treatment begins.

Pathology depth layers — how HS involvement extends from surface lesions to systemic dysfunction

Pathology depth layers — how HS involvement extends from surface lesions to systemic dysfunction

Clinical Observations

What Consistent Clinical Work With Complex HS Cases Shows

The insights below are not from a single case — they are patterns that appear repeatedly across patients with long-standing, treatment-resistant HS. They form the basis of the EPOH Protocol's phase structure.

01

The Gut Connection Is Underestimated — and Consistently Present

In patients with significant disease duration, gut dysfunction — impaired barrier function, disrupted microbiome, weakened digestive capacity — is present in the majority of cases. In many, repeated antibiotic courses have compounded this. The gut-skin axis in HS is not theoretical: correcting gut function reduces inflammatory load in a way that no surface treatment can replicate. The observation that patients who received gut-focused treatment stabilised faster than those who did not is one of the strongest clinical signals that shaped the Protocol.

02

Hormonal Patterns Are Frequently Overlooked in Women With HS

Women presenting with cyclical flare patterns — intensification around menstruation, or consistent worsening over a hormonal cycle — typically have an androgen-driven or insulin-resistance component that is not being addressed. Managing the flare without rebalancing the hormonal pattern means the same cycle will recur next month. PCOS-linked HS is a particularly clear example of a condition that requires hormonal correction as part of the primary treatment, not as an afterthought.

03

Treatment Sequence Determines Outcome More Than Treatment Intensity

Attempting to heal tissue before reducing inflammatory load produces limited results. Addressing hormones before stabilising the gut often leads to incomplete hormonal correction. The order in which internal systems are addressed matters — not because of protocol convention, but because of how biological systems interact. Phase F (tissue repair) is more effective when Phase I (gut and hormonal correction) has already shifted the internal environment. This sequencing insight is core to why the LIFES framework is structured the way it is.

04

Sustained Remission Requires a Stable Internal State, Not Ongoing Suppression

Patients maintained on long-term antibiotics or biologics often have stable numbers — controlled flare frequency, acceptable HbA1c equivalents in metabolic terms — but are not in remission. They are suppressed. The moment suppression is reduced, the disease reasserts. True remission is the absence of the internal conditions that drive flare formation — not the chemical prevention of their expression. The long-term aim of EPOH treatment is to produce a stable internal state where the triggers for HS no longer fire, not a state where their expression is blocked.

Working With Dr. Adil

What a Clinical Consultation at EPOH Actually Involves

This is not a GP appointment or a sales consultation. It is a structured clinical assessment. Here is what it covers.

🔍

Disease History Assessment

A detailed review of your HS history — onset, progression pattern, location, treatments tried and their effects, and any associated conditions. The duration and trajectory of your disease informs which phases of correction are most urgent.

⚙️

Internal Driver Identification

Assessment of gut function, hormonal patterns, metabolic markers, and immune status where relevant. The aim is to identify which internal systems are the primary drivers of your HS — because this determines what the treatment must address first.

🗺️

Stage & Subtype Mapping

HS behaves differently depending on location, structural pattern, and disease stage. Axillary HS in a patient with PCOS requires a different primary focus than perianal HS in a patient with obesity-linked metabolic dysfunction. Mapping your subtype determines the formulation approach.

📋

Honest Response Assessment

Not every patient is a suitable candidate for the EPOH Protocol. Cases with irreversible organ involvement, complete pancreatic failure, or advanced fibrosis beyond biological repair capacity are assessed honestly for response potential. This is not pessimism — it is clinical respect.

🌿

Personalised Treatment Plan

If the evaluation indicates suitable response potential, a treatment plan specific to your driver pattern is developed. This is not a printed protocol — it is constructed from your case. Formulations, phase sequencing, and lifestyle modifications are all tailored to your specific situation.

🔄

Ongoing Clinical Monitoring

Treatment is not a one-time prescription. As phases progress and internal conditions shift, formulations are adjusted. Clinical response, not calendar time, determines phase transitions. Monitoring continues through remission and into the stabilisation phase.

The Ayurvedic Framework

Why Ayurveda — and What That Actually Means at EPOH

The Ayurvedic system offers something that most chronic disease frameworks do not: a way of understanding why an individual's body produces a specific pattern of disease, rather than treating the disease as a standard entity.

At EPOH, Ayurveda is not used as a tradition or a philosophy — it is used as a clinical reasoning system. The concepts of Agni (digestive and metabolic function), Ama (accumulated inflammatory load), Rakta Dushti (blood-level imbalance), and Srotorodha (channel blockage and poor lymphatic clearance) map precisely onto the biological mechanisms of HS as understood by modern science.

This framework allows treatment to be personalised to an individual's internal pattern — not their diagnosis. Two patients with the same HS stage can have very different Ayurvedic profiles and require entirely different treatment approaches. That is the value of the framework: it provides the diagnostic structure to make personalisation systematic rather than guesswork.

Ayurvedic Mapping

Agni

≡

Digestive & metabolic function

Ama

≡

Accumulated inflammatory load / toxin burden

Rakta Dushti

≡

Blood-level inflammation driving skin involvement

Srotorodha

≡

Lymphatic stagnation and poor tissue clearance

Pitta aggravation

≡

Systemic heat and chronic inflammatory state

"Ayurveda should guide the thinking — not dominate the language."

Begin Here

If the Condition Is Recurring, a Structured Evaluation Is the Right Next Step

If your HS keeps coming back despite treatment, it usually means the root cause has not been addressed — not that the condition is untreatable. A clinical evaluation identifies what has been missed and whether this approach is the right fit for your case.

Speak With the Clinic on WhatsApp How Treatment Works

Dr. Adil Moulanchikkal, BAMS · EPOH · +91 88847 22246 · Personalised evaluation required before treatment begins

Go Deeper

The Thinking Behind the Approach

All Articles